CA
NZ
UK
AU
IND
US
…
Ludwig Enterprises, Inc. operates as a medical technology holding company. It engages in the developing of messenger ribonucleic acid (mRNA) genetic testing kits to treat inflammatory genetic markers associated with chronic diseases. The company was founded in 2006 and is based in Sparks, Nevada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Ludwig Enterprises Inc (LUDG.US) is quoted on the OTC Pink market; available public records do not clearly describe its core business or operations. As long-term growth drivers are not documented, investors may find the company attractive only if management provides verifiable revenue sources and a credible plan to support sustainable cash flow.
Material risks include absence of audited financial statements, very low trading liquidity, high price volatility, potential regulatory or delisting risk on the OTC market, and elevated operational or fraud risk common to thinly reported microcap issuers.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Income before tax | -0.01M | 0.13M | -0.01M | 0.06M | -0.07M |
| Minority interest | - | - | - | 0.00M | 0.00M |
| Net income | -0.01M | 0.13M | -0.01M | 0.06M | -0.07M |
| Selling general administrative | 0.01M | 0.00M | 0.01M | 0.04M | 0.07M |
| Gross profit | 0.00M | 0.14M | 0.00M | 0.10M | 0.00M |
| Ebit | -0.01M | 0.13M | -0.01M | 0.06M | -0.07M |
| Non operating income net other | - | - | - | 0.00M | 0.00M |
| Operating income | -0.01M | 0.13M | -0.01M | 0.06M | -0.07M |
| Other operating expenses | - | - | - | 0.00M | 0.00M |
| Interest expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Extraordinary items | - | - | - | 0.00M | 0.00M |
| Non recurring | - | - | - | 0.00M | 0.00M |
| Other items | - | - | - | 0.00M | 0.00M |
| Income tax expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total revenue | 0.00M | 0.14M | 0.00M | 0.10M | 0.00M |
| Total operating expenses | 0.00M | 0.00M | 0.00M | 0.04M | 0.07M |
| Cost of revenue | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total other income expense net | - | - | - | 0.00M | 0.00M |
| Discontinued operations | - | - | - | 0.00M | 0.00M |
| Net income from continuing ops | -0.01M | 0.13M | -0.01M | 0.06M | -0.07M |
| Net income applicable to common shares | -0.01M | 0.13M | -0.01M | 0.06M | -0.07M |
| Preferred stock and other adjustments | - | - | - | 0.00M | 0.00M |
| Breakdown | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Total assets | 0.01M | 0.01M | 0.02M | 0.03M | 0.09M |
| Intangible assets | - | - | 0.01M | 0.01M | 0.01M |
| Other current assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total liab | 0.01M | 0.01M | 0.16M | 0.16M | 0.39M |
| Total stockholder equity | -0.01M | -0.00M | -0.14M | -0.13M | -0.31M |
| Deferred long term liab | - | - | - | 0.00M | 0.00M |
| Other current liab | - | - | - | 0.00M | 0.00M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -0.35M | -0.34M | -0.47M | -0.47M | -0.52M |
| Other liab | 0.01M | 0.01M | 0.16M | 0.00M | 0.00M |
| Good will | - | - | - | 0.00M | 0.00M |
| Other assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Cash | 0.00M | 0.00M | 0.00M | 0.01M | 0.07M |
| Total current liabilities | 0.01M | 0.00M | - | 0.01M | 0.07M |
| Short term debt | 0.01M | 0.00M | - | 0.00M | 0.00M |
| Short long term debt | 0.01M | 0.00M | - | 0.00M | 0.00M |
| Other stockholder equity | - | - | -0.01M | -0.00M | 0.00M |
| Property plant equipment | - | - | - | 0.00M | 0.00M |
| Total current assets | 0.00M | 0.01M | 0.00M | 0.01M | 0.07M |
| Long term investments | - | - | - | 0.00M | 0.00M |
| Net tangible assets | -0.01M | -0.00M | -0.15M | -0.14M | -0.32M |
| Short term investments | - | - | - | 0.00M | 0.00M |
| Long term debt | - | - | - | 0.15M | 0.32M |
| Inventory | - | - | - | 0.00M | 0.00M |
| Accounts payable | - | - | - | 0.00M | 0.00M |
| Total permanent equity | - | - | - | 0.00M | 0.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 0.00M | 0.00M |
| Temporary equity redeemable noncontrolling interests | - | - | - | 0.00M | 0.00M |
| Accumulated other comprehensive income | - | - | - | 0.00M | 0.00M |
| Additional paid in capital | - | - | - | 0.00M | 0.00M |
| Common stock total equity | - | - | - | 0.00M | 0.00M |
| Preferred stock total equity | - | - | - | 0.00M | 0.00M |
| Retained earnings total equity | - | - | - | 0.00M | 0.00M |
| Treasury stock | - | - | - | 0.00M | 0.00M |
| Accumulated amortization | - | - | - | 0.00M | 0.00M |
| Non currrent assets other | - | - | - | 0.00M | 0.00M |
| Deferred long term asset charges | - | - | - | 0.00M | 0.00M |
| Non current assets total | - | - | - | 0.00M | 0.00M |
| Capital lease obligations | - | - | - | 0.00M | 0.00M |
| Long term debt total | - | - | - | 0.00M | 0.00M |
| Breakdown | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Investments | - | - | - | 0.00M | 0.00M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | - | - | - | 0.00M | 0.00M |
| Net borrowings | - | - | - | 0.00M | 0.00M |
| Total cash from financing activities | - | - | - | 0.00M | 0.00M |
| Change to operating activities | - | - | - | 0.00M | 0.00M |
| Net income | -0.01M | 0.13M | -0.01M | 0.06M | -0.07M |
| Change in cash | -0.00M | 0.00M | 0.00M | -0.04M | 0.00M |
| Total cash from operating activities | - | - | - | 0.00M | 0.00M |
| Depreciation | - | - | - | 0.00M | 0.00M |
| Other cashflows from investing activities | - | - | - | 0.00M | 0.00M |
| Dividends paid | - | - | - | 0.00M | 0.00M |
| Change to inventory | - | - | - | 0.00M | 0.00M |
| Change to account receivables | - | - | - | 0.00M | 0.00M |
| Sale purchase of stock | - | - | - | 0.00M | 0.00M |
| Other cashflows from financing activities | - | - | - | 0.00M | 0.00M |
| Change to netincome | - | - | - | -0.06M | 0.07M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change receivables | - | - | - | 0.00M | 0.00M |
| Cash flows other operating | - | - | - | 0.00M | 0.00M |
| Exchange rate changes | - | - | - | 0.00M | 0.00M |
| Cash and cash equivalents changes | - | - | - | 0.00M | 0.00M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| LUDG Ludwig Enterprises Inc |
- -% |
0.00 | - | - | 724.74 | - |
| ABT Abbott Laboratories |
- -% |
109.40 | 25.97 | 17.24 | 3.57 | 3.20 |
| MDT Medtronic PLC |
-0.41 0.41% |
98.88 | 26.60 | 15.87 | 3.35 | 2.08 |
| SYK Stryker Corporation |
3.74 1.22% |
310.55 | 29.23 | 16.86 | 4.18 | 4.51 |
| SEMHF Siemens Healthineers AG |
0.66 1.38% |
48.35 | 39.57 | 21.32 | 3.01 | 3.29 |
Ludwig Enterprises, Inc. operates as a medical technology holding company. It engages in the developing of messenger ribonucleic acid (mRNA) genetic testing kits to treat inflammatory genetic markers associated with chronic diseases. The company was founded in 2006 and is based in Sparks, Nevada.
3160 NW 1st Avenue, Pompano Beach, FL, United States, 33169
786-235-9026
1
| Name | Title | Year Born |
|---|---|---|
| Ms. Anne Blackstone CRNA | CEO & Director | NA |
| Mr. Patrick Greenish Jr. | Pres & Director | NA |
| Mr. Frank W. Yates Jr., Esq. | Councel | 1956 |
| Mr. Bohdan Stryzak | Chief Engineer & Project Mang. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.39%
Communication Services
+0.40%
Consumer Cyclical
-0.20%
Consumer Defensive
-0.56%
Energy
-0.45%
Financial Services
-0.09%
Financials
+0.11%
Healthcare
+0.40%
Industrials
+0.34%
Real Estate
-0.14%
Technology
+0.88%
Utilities
+0.11%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...